Font Size: a A A
Keyword [tamoxifen-resistance]
Result: 21 - 40 | Page: 2 of 4
21. To Explore The Mechanisms Of GPER-induced Tamoxifen Resistance In Breast Cancer By Microarray
22. Lapatinib Reverses ER-α36-associated Tamoxifen Resistance In Breast Cancer Cells
23. Effect Of PaX2 And AIB1 On Cell Growth And Tomoxifen Resistance Of Breast Cancer Cells
24. PRMT2 Affects Tamoxifen Resistance In Breast Cancer Cell Via The MAPK/ERK Pathway
25. A Preliminary Study Of Role Of PRMT2 In Tamoxifen Resistant Breast Cancer Cells
26. Investigation Of The Role Of ITGB1 In Gper-Induced Tamoxifen Resistance And The Underlying Mechanisms In Breast Cancer Cells
27. San Huang Decoction Inhibition Of PI3K/AKT Signaling Pathway And Reduce ROS Topromote MCF-7 Tamoxifen-resistant Cell Apoptosis
28. GPER Promotes Tamoxifen-resistance In ER+ Breast Cancer Through MAPK/Erk-TRIM2 Signaling Axis Reduced Bim Proteins
29. Study Of The Role And Targeted Therapy Of PI3K/AKT/mTOR And MiR-22/c-Myc Signaling Pathway In Breast Cancer
30. Establishment Of Tamoxifen Resistant Breast Cancer Cell Lines And Differential MiRNA Expression Among Taomoxifen Resistant Breast Cancer Cell Lines
31. Research Status Of Estrogen Receptor GPER In Breast Cancer
32. Mechnisms Of ObRb Downreg?lation Increases Breast Cancer Cell Sensitivity To Tamoxifen
33. The Function And Mechanism Study Of Shikonin Reducing Tamoxifen Resistance Through Long Non-coding RNA Uc.57 In Breast Cancer
34. The Mechanism Study On FEN1 Promotesthe Invasion And Resistance Of Tamoxifen In Breast Cancer Cells
35. The Function And Mechanism Of Transcriptional Coregulator NUPR1 In Tamoxifen Resistant Breast Cancer Cells
36. Metabolic Reprogramming Promotes The Tamoxifen Resistance In ER-Positive Breast Cancer
37. Study On The Mechanism Of Sanhuang Decoction Inhibiting PI3K/AKT Signaling Pathway In The Regulation Of Tamoxifen Resistance In Breast Cancer
38. Study On The Role And Mechanism Of NEMP1 In Tamoxifen Resistance Of Breast Cancer Cells
39. The LncRNA MAFG-AS1 Upregulated By Estrogen Promotes Progression Of ER Positive Breast Cancer Through MiR-339-5p/CDK2 Axis And Confers Tamoxifen Resistance
40. The Study Of PRRX1 Promotes Breast Cancer Epithelial Cell Occur EMT To Tamoxifen Resistance
  <<First  <Prev  Next>  Last>>  Jump to